South Carolina HCV Update 2020

South Carolina HCV Update

Saturday, October 17, 2020

9:00 a.m. – 1:00 p.m.

Online broadcast through Zoom© video-conferencing

Registration Information:

Participants must register to attend through the Southeast AETC website: https://www.seaetc.com/event/?ER_ID=71984

There is no cost to attend, but you must register by Friday, October 16^th to reserve your space. If you have any questions, please contact adrena.harrison@uscmed.sc.edu.

Target Audience: This educational event is for primary care physicians, nurse practitioners, physician assistants, pharmacists, nurses and other health care professionals that treat HCV and HIV.

Overall Goal: To enhance the capacity of participants to deliver high-quality care to individuals living with Hepatitis C.

Educational Methods: Lecture presentations with time for questions and answers will be used along with case-base discussions to facilitate the exchange of information and audience participation.

Agenda:

Time	Session
9:00-9:05 am	Welcome and Introduction of Speakers
9:05-9:50 am	Diagnosing and Staging HCV: Eric Meissner, MD, PhD
9:50-10:35 am	HCV Treatment Update: Divya Ahuja, MD
10:35-10:40 am	Break
10:40-11:25 am	HCV and Substance Abuse Disorder: Alain Litwin, MD, MPH, MS
11:25-11:55 am	Interdisciplinary Care for the HCV Patient: Caroline Derrick, PharmD, BCPS
11:55-12:00 pm	Break
12:00-12:30 pm	Interactive Session: HCV Case Studies: HCV Speaker Panel; Moderator
12:30-12:45 pm	Question and Answers, Evaluation, Adjourn

Date: Oct 17, 2020 09:00 AM - 12:45 PM

Fee

$0.00

CE Hours

3.25

CE Units

0.325

Activity Type

Knowledge

Target Audience(s)

Pharmacists

Accreditation(s)

The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

Requirements for CE Credit

Pharmacists must sign in at the beginning of the program, only claim credit for the sessions that they attended and participated in, in their entirety and then complete the online evaluation (with correct NABP ID and day/month of birth) within 30 days of event to ensure credit is transmitted to the CPE monitor. No partial credit will be awarded. Any credit claimed greater than 60 days will be rejected by the NABP CPE Monitor.

Sat, Oct 17, 2020

Diagnosing and Staging HCV

At the completion of this activity, the participant will be able to:

Discuss current screening recommendations and modalities for diagnosing HCV infection
Distinguish acute HCV infection, chronic HCV infection, and cleared HCV infection
Discuss strengths and limitations of non-invasive modalities to stage liver disease in chronic HCV infection

Speaker(s)/Author(s)

Eric Meissner, MD, PhD
Assistant Professor, Division of Infectious Diseases, Medical University of South Carolina

Activity Number

0062-9999-20-055-L01-P

Date: 10/17/20

Time: 09:05 AM - 09:50 AM

CE Hours

0.75

HCV Treatment Update

At the completion of this activity, the participant will be able to:

Discuss emerging developments in Hepatitis C
Discuss appropriate treatment regimens for Hepatitis C

Speaker(s)/Author(s)

Divya Ahuja, MD, MCRP
Associate Professor of Clinical Internal Medicine; UofSC School of Medicine

Activity Number

0062-9999-20-056-L01-P

Date: 10/17/20

Time: 09:50 AM - 10:35 AM

CE Hours

0.75

HCV and Substance Abuse Disorder

At the completion of this activity, the participant will be able to:

Discuss evidence-based models of care for improving HCV cascade of care for HCV-infected people who inject drugs
Identify simplified treatment paradigms for treating HCV-infected people who inject drugs
Describe rates of HCV reinfection among HCV-infected people who inject drugs and strategies to reduce these reinfection rates

Speaker(s)/Author(s)

Alain Litwin, MD, MPH, MS
Executive Director, Addiction Research Center; Vice Chair of Academics and Research, Prisma Health; Professor of Medicine, University of South Carolina School of Medicine–Greenville; Professor of Medicine, Clemson University School of Health Research

Activity Number

0062-9999-20-057-L01-P

Date: 10/17/20

Time: 10:40 AM - 11:25 AM

CE Hours

0.75

Interdisciplinary Care for the HCV Patient

At the completion of this activity, the participant will be able to:

Outline and apply the HCV care continuum utilizing a patient case
Identify unique medication-related issues within the HCV population

Speaker(s)/Author(s)

Caroline Derrick, PharmD, BCPS
Infectious Diseases Clinical Pharmacist, UofSC School of Medicine, Department of Internal Medicine, Prisma Health - Midlands

Activity Number

0062-9999-20-058-L01-P

Date: 10/17/20

Time: 11:25 AM - 11:55 AM

CE Hours

0.50

HCV Speaker Panel Interactive Session: Case Studies

At the completion of this activity, the participant will be able to:

Recognize clinical manifestations of HCV infection

Activity Number

0062-9999-20-059-L01-P

Date: 10/17/20

Time: 12:00 PM - 12:30 PM

CE Hours

0.50